Endocrine Oncology

Current Issue

Endocrine Oncology - Introducing our new Editor-in-Chief, Professor Justo P Castaño, University of Cordoba, Spain

Submit your manuscript Author guidelines Journal scope Open access Publication charges Editorial Board

Endocrine Oncology key journal metrics

Average time to first response: 43 days

Acceptance rate: 29%

EDITOR-IN-CHIEF

Justo P Castaño, PhD
Professor of Cell Biology,
Head, Hormones and Cancer Research Group,
Maimonides Biomedical Research Institute of Cordoba,
Reina Sofía University Hospital and University of Cordoba,
Spain

Browse the full Editorial Board

Visualization of protein–protein interactions of hormone receptors in hormone-dependent cancer research

Authors: Erina Iwabuchi, Yasuhiro Miki, Takashi Suzuki, and Hironobu Sasano

Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer

Authors: Damien A Leach, Rayzel C Fernandes, and Charlotte L Bevan

Diverse role of androgen action in human breast cancer

Authors: Kiyoshi Takagi, Mio Yamaguchi, Minoru Miyashita, Hironobu Sasano, and Takashi Suzuki

Hypoparathyroidism: an uncommon adverse effect of treatment with durvolumab

Authors: Alexander Kreze, Matěj Homer, Tereza Barešová, and Kristina Klemperová

Transient remission of hyperparathyroidism after fine-needle aspiration biopsy

Authors: Ana Rita Elvas, Andreia Martins Fernandes, Sara Reis, Joana Couto, Raquel G Martins, Jacinta Santos, Teresa Martins, Bernardo Marques, Joana Guimarães, and Fernando J C Rodrigues

Epidemiology of craniopharyngiomas: a population-based study in Malta

Authors: Sarah Craus and Mark Gruppetta

Volume 1: Issue 1,
Pages:: 9–16 (8 total)

Adrenocortical cancer recurrence following initial transcutaneous biopsy: a rare demonstration of needle tract seeding

Authors: Nada Younes, Isabelle Bourdeau, Harold Olney, Paul Perrotte, Odile Prosmanne, Mathieu Latour, David Roberge, and André Lacroix

Volume 1: Issue 1,
Pages:: K7–K12

Investigating the clinical, pathological and molecular profile of oncocytic adrenocortical neoplasms: a case series and literature review

Authors: Eleanor Fewings, Serena Khoo Sert Kim, Alexey Larionov, Alison Marker, Olivier Giger, Ashley Shaw, Graeme R Clark, Vasilis Kosmoliaptsis, Benjamin G Challis, Marc Tischkowitz, and Ruth T Casey

Volume 1: Issue 1,
Pages:: 33–44 (12 total)

Hypoxia stimulates angiogenesis and a metabolic switch in human parathyroid adenoma cells

Authors: K E Lines, M Stevenson, R Mihai, I V Grigorieva, O A Shariq, K U Gaynor, J Jeyabalan, M Javid, and R V Thakker

Volume 1: Issue 1,
Pages:: 23–32 (10 total)

FOXE1 polymorphism rs965513 predisposes to thyroid cancer in a European cohort

Authors: Patrick W Owens, Terri Patricia McVeigh, Nicola Miller, Carole Guerin, Frederic Sebag, Denis Quill, Marcia Bell, Michael J Kerin, and Aoife J Lowery

Volume 1: Issue 1,
Pages:: 1–8 (8 total)

January 26, 2021

Article Publication Charge Waived

In celebration of the launch of Endocrine Oncology, Bioscientifica is sponsoring the Article Publication Charge during the launch years of the journal.

January 26, 2021

Endocrine Oncology – now open for submissions

Bioscientifica is pleased to announce the launch of their new fully open-access, peer-reviewed journal, Endocrine Oncology, endorsed by the Society for Endocrinology.

Led by Editor-in-Chief Edward P Gelmann, Endocrine Oncology will see vigorous yet rapid peer review of the latest basic, translational and clinical research in the field.

RSS Feed

More News

Tweets by EndoOncology